IA_2期宫颈癌患者根治性子宫切除术的临床效果分析  

Clinical Efficacy of Stage IA_2 Cervical Cancer Treated with Radical Hysterectomy

作　　者：李晓锋[1] 高强[1] 

机构地区：[1]中国人民解放军第九二医院,353000

出　　处：《实用癌症杂志》2015年第5期682-684,共3页The Practical Journal of Cancer

摘　　要：目的评估IA2期宫颈癌患者根治性子宫切除术的手术效果。方法回顾性分析行改良根治性子宫切除术18例患者的临床资料,包括临床病理危险因素(淋巴结转移,宫旁受累),辅助治疗,1年无病生存率和1年总生存率。结果 1年无病生存期和1年总生存率分别为89.7%和97.4%,1例(5.5%)患者盆腔淋巴结转移。年龄,细胞学类型,淋巴血管间隙浸润,阴道切缘和淋巴结状态与生存预后无显著相关性。IA2期宫颈癌患者的手术效果和生存预后均良好。结论对IA2期宫颈癌患者行子宫切除盆腔淋巴结清扫术疗效好。Objective To evaluate the surgical outcomes of patients with stage IA2 cervical cancer treated with radical hysterectomy. Methods Data of 58 patients who underwent modified radical hysterectomy were retrospectively reviewed. The analysis included clinicopathological risk factors( nodal metastasis,parametrial involvement),adjuvant treatment,1-year diseasefree survival and 1-year overall survival. Results 1-year disease-free survival and 1-year overall survival rates were 89. 7% and97. 4%. 1 patient( 5. 5%) had pelvic lymph node metastases. There was no statistically significant association between survival and prognostic factors such as age,histological cell type,lymph-vascular space invasion,vaginal margin status and lymph node status. Surgical and survival outcomes of patients with stage IA2 cervical cancer were excellent. Conclusion Stage IA2 cervical cancer treated with radical hysterectomy is effective.

关 键 词：宫颈癌 IA2期 微创宫颈癌 

分 类 号：R737.33[医药卫生—肿瘤]